Hematology and Hematopathology
Clinical Resources
- Communiqué: Current Approach to Diagnosis and Management of Chronic Lymphocytic Leukemia
- Communiqué: FISH Analysis Provides Important Prognostic Information in B-Cell Chronic Lymphocytic Leukemia
- Hot Topic: Middleware and the Clinical Hematology Laboratory
- Hot Topic: Chronic Lymphocytic Leukemia - New Approaches for a Common Disease
- Hot Topic: Monitoring Monoclonal Gammopathies
- Hot Topic: Common Test-Ordering Errors, Part 4: JAK2 on Blood and Bone Marrow/Free Thyroxine index (FTI) and T3 Uptake
- Hot Topic: Classic Myeloproliferative Neoplasms
- More...
Mayo Clinic Links
Advances in Hematologic Disorder Testing
Developments in Diagnosis, Management, and Treatment
- Thrombotic Microangiopathy (TMA)
- Plasma Cell Disorders
- Hereditary Erythrocytosis
- Lymphoma
- Diagnostic Immunology Post-HCT
- Hematology Cytogenetics
Thrombotic Microangiopathy (TMA)
Facilitate Prompt Diagnosis and Management of Patients with TMA
Thrombotic microangiopathy is a group of disorders characterized by thrombocytopenia and microangiopathic hemolytic anemia, neurological symptoms, fever, and renal dysfunction that can cause ischemic organ injury to the brain, kidneys, heart, pancreas, liver, and lungs. Because of the variety of TMA disorders and different treatment options for each, prompt and accurate diagnosis can significantly impact a patient’s outcome.
Test Utilization for Plasma Cell Disorders
Expanded Results and Improved Predictive Benefits
Previously, a common component of diagnosing multiple myeloma and other plasma cell disorders was the plasma cell labeling index analysis, which looked only at clonality and proliferative rates.
Our new flow cytometric-based test offers expanded results and improved predictive benefits.
Diagnostic Hematology Testing
Diagnostic hematopathology has become an increasingly complex subspecialty, particularly with neoplastic disorders of blood and bone marrow. With Mayo Clinic's specialty laboratories, we offer a comprehensive menu of screening, diagnostic, prognostic, and monitoring tests for hematopoietic diseases.
Our Consultants
The Division of Hematopathology works collaboratively with the Division of Hematology to create an integrated approach to disease management and to drive the conception, development, and validation of novel tests and approaches to continuously improve the laboratory tests available for this purpose.
The staff physicians and allied health staff who comprise the Mayo Clinic Division of Hematopathology provide unmatched expertise in the diagnosis of benign and malignant hematologic disorders.
External
link
PDF
document
Excel
document
Word
document